K

Kardigan

Biotech firm developing cardiovascular medicines

Director, Investor Relations

Finance & BankingConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA$200k - $260k

About the Job

Requirements

  • A bachelor's degree or higher in biological or medical sciences, finance, business, economics, accounting, communications, or a related discipline.
  • Demonstrated experience developing and executing investor relations strategies, preferably within a U.S. publicly traded company.
  • Ability to develop sophisticated investor communications and translate complex financial, pipeline, and business information into compelling investment narratives.
  • Experience managing institutional investor and analyst relationships, including direct participation in investor meetings and conferences.
  • Ability to engage effectively with senior leadership and external stakeholders through written and verbal communication.
  • Strong analytical capabilities and ability to synthesize financial, operational, and market information into actionable recommendations.
  • Demonstrated leadership, project management, and stakeholder management skills.
  • Professionalism, integrity, discretion, and judgment when handling confidential or market-sensitive information.
  • Ability to work independently, prioritize competing demands, and perform effectively in a dynamic, deadline-driven environment.
  • Advanced proficiency in Microsoft PowerPoint, Excel, and relevant financial information and investor relations platforms.

Responsibilities

  • Support the Head of Investor Relations in developing and executing the company's investor relations strategy and ensure consistent communication of the investment thesis, business performance, and strategic priorities.
  • Build and maintain direct relationships with institutional investors, sell-side analysts, and other capital markets participants, representing the company within the investment community.
  • Lead investor and analyst meetings independently or alongside senior leadership, and respond to questions regarding pipeline candidates, company performance, strategy, and market developments.
  • Participate in investor conferences, non-deal roadshows, investor days, and other engagement activities, including preparing materials, briefing executives, tracking engagement, and conducting investor follow-up.
  • Develop understanding of shareholder perspectives, analyst expectations, and investor sentiment, and share insights with the Head of Investor Relations and senior management.
  • Develop understanding of the company's pipeline, disease areas, indications, and strategic initiatives, including competitive positioning, growth drivers, and key milestones.
  • Serve as the principal investor relations liaison for assigned business areas, working with Medical, Research, Regulatory, and other cross-functional teams.
  • Develop investor-facing narratives, presentations, Q&A materials, and supporting analysis for assigned business areas.
  • Monitor industry trends, competitor activity, market dynamics, and external developments to inform investor messaging and engagement.
  • Support investor communications concerning data readouts, product launches, commercial milestones, strategic developments, and other significant events in assigned areas.
  • Identify potential investor questions, market misunderstandings, and opportunities to improve external understanding of the company's business.
  • Lead preparation of quarterly and annual earnings communications, including earnings releases, conference call scripts, investor presentations, executive talking points, and Q&A documents.
  • Work with Medical Affairs, Finance, and other internal stakeholders to develop accurate messages around medical conferences and quarterly earnings.
  • Support development and refinement of the company's investment narrative and key investor communication materials.
  • Ensure materials align with company disclosure policies and applicable regulatory requirements.
  • Work with the Head of Investor Relations and senior leadership to deliver key investor relations priorities.
  • Partner with company functions to ensure accurate and consistent investor messaging.
  • Own assigned investor relations projects and initiatives, managing timelines, stakeholders, and deliverables.
  • Provide guidance and support to more junior investor relations team members where appropriate.
  • Identify opportunities to enhance investor engagement, improve internal investor relations processes, and strengthen investor communications.

Desired Qualifications

  • At least eight years of relevant professional experience in investor relations, equity research, investment banking, corporate finance, financial communications, or related capital markets functions.
  • PhD, MD, MBA, CFA designation, or another relevant advanced qualification.
  • Previous investor relations leadership experience in the biotechnology or pharmaceutical sector at a publicly traded company.
  • Established relationships with institutional investors, sell-side analysts, or relevant capital markets participants.
  • Familiarity with SEC reporting, Regulation FD, and relevant financial disclosure requirements.
  • Familiarity with investor relations customer relationship management platforms and shareholder analytics tools.
  • Experience supporting investor events or capital markets days, strategic corporate initiatives, or major financial communications events.
  • Previous experience managing direct reports, agencies, or external investor relations advisors.

About the Company

Kardigan

Biotech firm developing cardiovascular medicines

Kardigan develops medicines to prevent and treat cardiovascular disease. It focuses on discovering and developing multiple cardiovascular therapies at a rapid pace, using deep expertise in heart-health drug development to move candidates from research toward commercialization. Their product approach centers on creating medicines that address heart disease more effectively and earlier in the disease process. Kardigan differentiates itself through a leadership team of seasoned biopharma veterans and a commitment to modernizing how cardiovascular drugs are discovered and developed, aiming to bring therapies to patients faster and more efficiently. The company’s goal is to reduce the global burden of cardiovascular disease by providing safe, effective medicines that prevent progression or cure conditions related to heart health.

Company size
201-500
Company stage
IPO
Headquarters
West Windsor Township, NJ
Founded
2023

Recently Posted Jobs

Explore more opportunities at Kardigan

See more jobs